Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Decibel Cannabis Company ( (TSE:DB) ) just unveiled an update.
Decibel Cannabis Company has secured new credit facilities totaling $61 million from ATB Financial and ATB Cormark Capital Markets, refinancing its existing debt and extending maturities to February 2030. The package comprises a $40 million first lien term facility replacing a loan due in 2027, a $10 million revolving facility for flexible corporate development funding, and an $11 million second lien term facility that reshapes 2026 obligations without increasing total liabilities.
Management said the financing leaves Decibel free cash flow positive with no material near-term maturities and strengthens its balance sheet at a time when capital remains tight across the cannabis industry. The expanded revolver and term structure are intended to support domestic growth in ready-to-consume categories and accelerate international expansion, particularly leveraging the AgMedica facility, while targeting a debt-to-EBITDA ratio under 2.0 times.
The most recent analyst rating on (TSE:DB) stock is a Buy with a C$0.10 price target. To see the full list of analyst forecasts on Decibel Cannabis Company stock, see the TSE:DB Stock Forecast page.
Spark’s Take on TSE:DB Stock
According to Spark, TipRanks’ AI Analyst, TSE:DB is a Neutral.
The overall stock score of 64 reflects a company with growth potential but facing operational and liquidity challenges. The financial performance is moderate, with revenue growth and improved leverage, but profitability and cash flow issues need addressing. Technical analysis indicates a bearish trend, though valuation suggests the stock is undervalued, offering potential for capital gains.
To see Spark’s full report on TSE:DB stock, click here.
More about Decibel Cannabis Company
Decibel Cannabis Company Inc. is a Canadian consumer-focused cannabis producer specializing in premium cannabis and extract manufactured products. Its leading brands, including General Admission, Qwest and Standard Issue, are sold across Canada and are beginning to reach international markets. The company operates processing and manufacturing in Calgary, cultivation sites in British Columbia and Saskatchewan, and an EUGMP-licensed facility in Chatham, Ontario to support its global ambitions.
Average Trading Volume: 286,962
Technical Sentiment Signal: Sell
Current Market Cap: C$51.92M
Learn more about DB stock on TipRanks’ Stock Analysis page.